Skip to main content

HOLLENCREST CAPITAL MANAGEMENT

Position in PFE — Pfizer Inc

CIK 1161722 NEWPORT BEACH, CA

Position in PFE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$21,214
-$3,019 QoQ
Shares Held
881
+2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,704
of 2,820 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Derivatives in PFE

reported options exposure · as of Sep 30, 2024
CallValue
$2,894
CallShares
100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

HOLLENCREST CAPITAL MANAGEMENT holds $5,976,653 across 13 Drug Manufacturers - General names. PFE ranks #8 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 PFE
Pfizer Inc
This page
881 $21,214

All Filings in PFE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,214 881
2026-03-31 $24,233 863
2025-12-31 $21,488 863
2025-09-30 $21,989 863
2025-06-30 $32,602 1,345
2025-03-31 $34,082 1,345
2024-12-31 $35,921 1,354
2024-09-30 $2,894 100
2024-09-30 $44,249 1,529
2024-06-30 $54,085 1,933
2024-03-31 $53,002 1,910
2023-12-31 $311,479 10,819
2023-09-30 $358,833 10,818
2023-06-30 $404,176 11,019
2023-03-31 $468,384 11,480
2022-12-31 $175,087 3,417
2022-06-30 $323,911 6,178
2022-03-31 $298,297 5,762
2021-12-31 $331,152 5,608
2021-09-30 $234,490 5,452
2021-06-30 $265,934 6,791
2021-03-31 $2,203,833 60,829
2020-12-31 $2,699,313 73,331
2020-09-30 $2,652,783 72,283
2020-06-30 $2,379,809 72,777
2020-03-31 $2,321,646 71,129